ANKFY1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.16493489801906E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.94750010457301E-10 |
Normal-vs-Stage2 |
1.7369999882888E-09 |
Normal-vs-Stage3 |
3.21964677141295E-15 |
Normal-vs-Stage4 |
2.73739919620652E-11 |
Stage1-vs-Stage2 |
1.339200E-01 |
Stage1-vs-Stage3 |
6.974300E-04 |
Stage1-vs-Stage4 |
1.903950E-02 |
Stage2-vs-Stage3 |
3.335600E-01 |
Stage2-vs-Stage4 |
6.428200E-01 |
Stage3-vs-Stage4 |
6.421200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62725388719309E-12 |
Normal-vs-AfricanAmerican |
5.80939999994534E-07 |
Normal-vs-Asian |
9.137800E-01 |
Caucasian-vs-AfricanAmerican |
9.556400E-01 |
Caucasian-vs-Asian |
3.523000E-03 |
AfricanAmerican-vs-Asian |
2.651700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.66453525910038E-15 |
Normal-vs-Female |
1.04739994455372E-09 |
Male-vs-Female |
9.255100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.99809999948897E-08 |
Normal-vs-Age(41-60Yrs) |
4.61239935134472E-11 |
Normal-vs-Age(61-80Yrs) |
1.7071899449661E-12 |
Normal-vs-Age(81-100Yrs) |
4.05670000036551E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.184800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.837200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.616200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.489000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.251400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.789400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.731000E-01 |
Normal-vs-Grade 2 |
1.94609883763519E-11 |
Normal-vs-Grade 3 |
2.00650607240505E-12 |
Normal-vs-Grade 4 |
1.98663308026426E-12 |
Grade 1-vs-Grade 2 |
3.039900E-02 |
Grade 1-vs-Grade 3 |
1.078300E-02 |
Grade 1-vs-Grade 4 |
2.276400E-03 |
Grade 2-vs-Grade 3 |
7.855500E-02 |
Grade 2-vs-Grade 4 |
3.884700E-03 |
Grade 3-vs-Grade 4 |
1.427800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.00980002137874E-09 |
Normal-vs-ccB subtype |
2.16116013973533E-12 |
ccA subtype-vs-ccB subtype |
3.460200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.20089502178666E-11 |
Normal-vs-N1 |
7.626000E-02 |
N0-vs-N1 |
6.376600E-01 |
|
|